Search
for
Sort by
Research 61–90 of 119
- Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Nilontinib induced keratosis pilaris atrophicans
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Axitinib-induced repigmentation of grey hair in a patient with metastatic renal cell carcinoma
- Uloga folikularnih matičnih stanica u patofiziologiji alopecije areate
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Identification and characterization of Birt–Hogg–Dubé associated renal carcinoma
- Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning
- Prophylaxis and Management of Skin Toxicities
- The trichoscopic features of hair shaft anomalies induced by epidermal growth factor receptor inhibitors: A case series
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study
- 7410 Bevacizumab Induced Hypothyroidism
- Erlotinib-induced trichomegaly of eyelashes in lung cancer treatment: Epidermal growth factor receptor inhibitor side effect
- Dissecting the genetic variations associated with response to first-line chemotherapy in patients with small cell lung cancer: a retrospective cohort study
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Tumor Angiogenesis and Anti-angiogenic Therapy
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Targeting integrin pathways: mechanisms and advances in therapy
- 9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Recent advances on skin‐resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti‐aging and cancer therapies
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022